These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 24005169)
1. Evaluation of the prognostic role of pSTAT3 expression in temporal bone squamous cell carcinoma. Marioni G; Nucci R; Marino F; Cappellesso R; Pillon M; Zanoletti E; Giacomelli L; Franchella S; Billo P; Pareschi R; Martini A Otol Neurotol; 2013 Oct; 34(8):1476-82. PubMed ID: 24005169 [TBL] [Abstract][Full Text] [Related]
2. Neoangiogenesis in temporal bone carcinoma: the prognostic role of CD105. Marioni G; Nucci R; Marino F; Giacomelli L; Rugge M; Pareschi R; Martini A Otol Neurotol; 2012 Jul; 33(5):843-8. PubMed ID: 22643443 [TBL] [Abstract][Full Text] [Related]
3. Expression of the tumour-suppressor maspin in temporal bone carcinoma. Marioni G; Zanoletti E; Stritoni P; Lionello M; Giacomelli L; Gianatti A; Cattaneo L; Blandamura S; Mazzoni A; Martini A Histopathology; 2013 Aug; 63(2):242-9. PubMed ID: 23730906 [TBL] [Abstract][Full Text] [Related]
4. Temporal bone squamous cell carcinoma: analyzing prognosis with univariate and multivariate models. Zanoletti E; Marioni G; Stritoni P; Lionello M; Giacomelli L; Martini A; Mazzoni A Laryngoscope; 2014 May; 124(5):1192-8. PubMed ID: 24108656 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for squamous cell carcinoma of the temporal bone: extensive bone involvement or extensive soft tissue involvement? Ito M; Hatano M; Yoshizaki T Acta Otolaryngol; 2009 Nov; 129(11):1313-9. PubMed ID: 19863330 [TBL] [Abstract][Full Text] [Related]
6. Roles of epithelial-mesenchymal transition in squamous cell carcinoma of the temporal bone. Sugimoto H; Ito M; Hatano M; Kondo S; Suzuki S; Yoshizaki T Otol Neurotol; 2011 Apr; 32(3):483-7. PubMed ID: 21358455 [TBL] [Abstract][Full Text] [Related]
7. Recurrent squamous cell carcinoma of the temporal bone: critical analysis of cases with a poor prognosis. Zanoletti E; Marioni G; Franchella S; Lovato A; Giacomelli L; Martini A; Mazzoni A Am J Otolaryngol; 2015; 36(3):352-5. PubMed ID: 25595048 [TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma involving the temporal bone: lateral temporal bone resection as primary intervention. Lassig AA; Spector ME; Soliman S; El-Kashlan HK Otol Neurotol; 2013 Jan; 34(1):141-50. PubMed ID: 23202152 [TBL] [Abstract][Full Text] [Related]
9. Temporal bone carcinoma: a first glance beyond the conventional clinical and pathological prognostic factors. Marioni G; Martini A; Favaretto N; Franchella S; Cappellesso R; Marino F; Blandamura S; Mazzoni A; Zanoletti E Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):2903-10. PubMed ID: 26518208 [TBL] [Abstract][Full Text] [Related]
10. Survival outcomes in surgical treatment of 72 cases of squamous cell carcinoma of the temporal bone. Chi FL; Gu FM; Dai CF; Chen B; Li HW Otol Neurotol; 2011 Jun; 32(4):665-9. PubMed ID: 21436754 [TBL] [Abstract][Full Text] [Related]
11. Analysis of 95 cases of squamous cell carcinoma of the external and middle ear. Yin M; Ishikawa K; Honda K; Arakawa T; Harabuchi Y; Nagabashi T; Fukuda S; Taira A; Himi T; Nakamura N; Tanaka K; Ichinohe M; Shinkawa H; Nakada Y; Sato H; Shiga K; Kobayashi T; Watanabe T; Aoyagi M; Ogawa H; Omori K Auris Nasus Larynx; 2006 Sep; 33(3):251-7. PubMed ID: 16431060 [TBL] [Abstract][Full Text] [Related]
12. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer. Haura EB; Zheng Z; Song L; Cantor A; Bepler G Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287 [TBL] [Abstract][Full Text] [Related]
13. The problem of nodal disease in squamous cell carcinoma of the temporal bone. Zanoletti E; Danesi G Acta Otolaryngol; 2010 Aug; 130(8):913-6. PubMed ID: 20524790 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Serine-Phosphorylated STAT3 Expression in pT1-T2 Oral Tongue Carcinoma. Fasanaro E; Staffieri C; Cappellesso R; Marino F; Ottaviano G; Val M; Giacomelli L; de Filippis C; Stellini E; Staffieri A; Marioni G Clin Exp Otorhinolaryngol; 2015 Sep; 8(3):275-80. PubMed ID: 26330924 [TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin expression and laryngeal squamous cell carcinoma prognosis: novel preliminary evidence. Marioni G; Staffieri A; Giacomelli L; Lionello M; Guzzardo V; Busnardo A; Blandamura S Histopathology; 2011 Jun; 58(7):1148-56. PubMed ID: 21707714 [TBL] [Abstract][Full Text] [Related]
17. Pathologically determined tumor volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma. Nixon IJ; Palmer FL; Lakin P; Kattan MM; Lee NY; Ganly I JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1151-5. PubMed ID: 24092047 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Haughey BH; Sinha P Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of IGF1R expression in non-small-cell lung cancer. Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293 [TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma of the temporal bone: results and management. Kunst H; Lavieille JP; Marres H Otol Neurotol; 2008 Jun; 29(4):549-52. PubMed ID: 18520589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]